Generali Investments Cee, Investicni Spolecnost, A.S. Amgen Inc Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $970 Billion
- Q4 2024
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Amgen Inc stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 14,720 shares of AMGN stock, worth $4.38 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
14,720Holding current value
$4.38 Million% of portfolio
0.4%Shares
1 transactions
Others Institutions Holding AMGN
# of Institutions
3,091Shares Held
406MCall Options Held
7.57MPut Options Held
7.16M-
Vanguard Group Inc Valley Forge, PA52.4MShares$15.6 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.73 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.38 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.25 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $159B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...